4-Chloro-6-iodothieno[2,3-d]pyrimidine, 97.0%, 1g

(R)-1,3,4,6,7,12b-hexahydro-2H-benzofuro[2,3-a]quinolizin-2-one, 97%, 100mg

2,7-Dichloro-6-methoxybenzo[d]thiazole, 95.0%, 250mg

trans-Cinnamic Acid [Matrix for MALDI-TOF/MS]>99.5%(GC)(T)1g

N-Boc-1,6-Diaminohexane, 95.0%, 10g

5-Fluoro-2-nitrophenol, 98.0%, 250g

Acridine hydrochloride, 95.0%, 5g

2-[3-(propan-2-yl)phenoxy]acetic acid, 95%, 250mg

1-Pyrrolidinecarboxylic acid, 3-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-, phenylmethyl ester, (3R)-, 95%, 1g

6-Methoxy-1H-benzo[d]imidazole-2-sulfonic acid, 97%, 5g

2-Butylbenzo[d]isothiazol-3(2H)-one, 97.0%, 1g

tert-Butyl 5-bromo-1H-indazole-1-carboxylate, 98.0%, 100mg

2-(4-Isopropyl-piperazin-1-yl)-ethylamine, 95.0%, 1g